Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 31,636 articles published since 2008
|||| 49 

These are the 31636 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
76 Guideline NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. 2010

Kulke, Matthew H / Anthony, Lowell B / Bushnell, David L / de Herder, Wouter W / Goldsmith, Stanley J / Klimstra, David S / Marx, Stephen J / Pasieka, Janice L / Pommier, Rodney F / Yao, James C / Jensen, Robert T / Anonymous4950666. ·Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA 02115, USA. Matthew_kulke@dfci.harvard.edu ·Pancreas · Pubmed #20664472.

ABSTRACT: Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.

77 Guideline Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. 2010

Del Chiaro, Marco / Zerbi, Alessandro / Capurso, Gabriele / Zamboni, Giuseppe / Maisonneuve, Patrick / Presciuttini, Silvano / Arcidiacono, Paolo Giorgio / Calculli, Lucia / Falconi, Massimo / Anonymous7420665. ·Division of General and Transplant Surgery, Pisa University Hospital, Via Paradisa 2, 56124 Cisanello, Pisa, Italy. m.delchiaro@ao-pisa.toscana.it ·Dig Liver Dis · Pubmed #20627831.

ABSTRACT: In Italy, pancreatic cancer is the fifth leading cause of tumor related death with about 7000 new cases per year and a mortality rate of 95%. In a recent prospective epidemiological study on the Italian population, a family history was found in about 10% of patients suffering from a ductal adenocarcinoma of the pancreas (PDAC). A position paper from the Italian Registry for Familial Pancreatic Cancer was made to manage these high-risk individuals. Even though in the majority of high-risk individuals a genetic test to identify familial predisposition is not available, a screening protocol seems to be reasonable for subjects who have a >10-fold greater risk for the development of PDAC. However this kind of screening should be included in clinical trials, performed in centers with high expertise in pancreatic disease, using the least aggressive diagnostic modalities.

78 Guideline Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2010

Cascinu, S / Falconi, M / Valentini, V / Jelic, S / Anonymous3340663. ·Department of Medical Oncology, Università Politecnica delle Marche, Ancona, Italy. ·Ann Oncol · Pubmed #20555103.

ABSTRACT: -- No abstract --

79 Guideline Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2010

Oberg, K / Akerström, G / Rindi, G / Jelic, S / Anonymous3170663. ·Department of Endocrine Oncology, University Hospital, Uppsala, Sweden. ·Ann Oncol · Pubmed #20555086.

ABSTRACT: -- No abstract --

80 Guideline Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. 2010

Janson, Eva Tiensuu / Sørbye, Halfdan / Welin, Staffan / Federspiel, Birgitte / Grønbaek, Henning / Hellman, Per / Mathisen, Oystein / Mortensen, Jann / Sundin, Anders / Thiis-Evensen, Espen / Välimäki, Matti J / Oberg, Kjell / Knigge, Ulrich. ·Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Tiensuu_Janson@medsci.uu.se ·Acta Oncol · Pubmed #20553100.

ABSTRACT: The diagnostic work-up and treatment of patients with neuroendocrine tumours has undergone a major change during the last decade. New diagnostic possibilities and treatment options have been developed. These Nordic guidelines, written by a group with a major interest in the subject, summarises our current view on how to diagnose and treat these patients. The guidelines are meant to be useful in the daily practice for clinicians handling patients with neuroendocrine tumours.

81 Guideline [Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part II)]. 2010

Navarro, Salvador / Vaquero, Eva / Maurel, Joan / Bombí, Josep Antoni / De Juan, Carmen / Feliu, Jaime / Fernández Cruz, Laureano / Ginés, Angels / Girela, Enrique / Rodríguez, Ricardo / Sabater, Luis / Anonymous1440657 / Anonymous1450657 / Anonymous1460657 / Anonymous1470657 / Anonymous1480657 / Anonymous1490657. ·Servicio de Gastroenterología, CIBERehd, IDIBAPS, Hospital Clínic, Universitat de Barcelona, Barcelona, España. snavarro@clinic.ub.es ·Med Clin (Barc) · Pubmed #20356609.

ABSTRACT: -- No abstract --

82 Guideline [Recommendations for diagnosis, staging and treatment of pancreatic cancer (Part I). Grupo Español de Consenso en Cáncer de Páncreas]. 2010

Navarro, Salvador / Vaquero, Eva / Maurel, Joan / Bombí, Josep Antoni / De Juan, Carmen / Feliu, Jaime / Fernández Cruz, Laureano / Ginés, Angels / Girela, Enrique / Rodríguez, Ricardo / Sabater, Luis / Anonymous44180656 / Anonymous44190656 / Anonymous44200656 / Anonymous44210656 / Anonymous44220656 / Anonymous44230656. ·Servicio de Gastroenterología, CIBERehd, IDIBAPS, Hospital Clínic, Universitat de Barcelona, Barcelona, España. snavarro@clinic.ub.es ·Med Clin (Barc) · Pubmed #20346471.

ABSTRACT: -- No abstract --

83 Guideline ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors. 2009

Akerström, Göran / Falconi, Massimo / Kianmanesh, Reza / Ruszniewski, Philippe / Plöckinger, Ursula / Anonymous1010637 / Anonymous1020637. ·Department of Surgery, Uppsala University Hospital, SE-751 85 Uppsala, Sweden. goran.akerstrom@kirurgi.uu.se ·Neuroendocrinology · Pubmed #19713712.

ABSTRACT: -- No abstract --

84 Guideline ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers. 2009

O'Toole, Dermot / Grossman, Ashley / Gross, David / Delle Fave, Gianfranco / Barkmanova, Jaroslava / O'Connor, Juan / Pape, Ulrich-Frank / Plöckinger, Ursula / Anonymous990637 / Anonymous1000637. ·Department of Gastroentereology and Clinical Medicine, St. James's Hospital and Trinity College, Dublin 8, Ireland. otooled1@tcd.ie ·Neuroendocrinology · Pubmed #19713711.

ABSTRACT: -- No abstract --

85 Guideline ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. 2009

Klöppel, Günter / Couvelard, Anne / Perren, Aurel / Komminoth, Paul / McNicol, Anne-Marie / Nilsson, Ola / Scarpa, Aldo / Scoazec, Jean-Yves / Wiedenmann, Bertram / Papotti, Mauro / Rindi, Guido / Plöckinger, Ursula / Anonymous1150617 / Anonymous1160617. ·Institut für Allgemeine Pathologie und Pathologische Anatomie, Universität Kiel, DE-24105 Kiel, Germany. guenterkloeppel@path.uni-kiel.de ·Neuroendocrinology · Pubmed #19060454.

ABSTRACT: -- No abstract --

86 Guideline Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. 2008

Herrmann, R / Jelic, S / Anonymous3450598. ·Division of Oncology, Department of Internal Medicine, University Hospital of Basel, Basel, Switzerland. ·Ann Oncol · Pubmed #18456756.

ABSTRACT: -- No abstract --

87 Guideline Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. 2008

Oberg, K / Jelic, S / Anonymous3300598. ·Department of Endocrine Oncology, University Hospital, Uppsala, Sweden. ·Ann Oncol · Pubmed #18456741.

ABSTRACT: -- No abstract --

88 Editorial Chronic pancreatitis-like changes in individuals at high risk for the development of pancreatic cancer: What is the significance? 2019

Brewer Gutierrez, Olaya I / Lennon, Anne Marie. ·Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, Maryland, USA. ·Gastrointest Endosc · Pubmed #30902206.

ABSTRACT: -- No abstract --

89 Editorial Pain relief and the celiac plexus: Can burning exceed injecting? 2019

Benson, Mark / Pfau, Patrick. ·Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. ·Gastrointest Endosc · Pubmed #30567685.

ABSTRACT: -- No abstract --

90 Editorial Dosage of Atg5 Gene Affects Pancreatic Tumorigenesis and Progression. 2019

Han, Haiyong. ·Molecular Medicine Division, Translational Genomics Research Institute, Phoenix, Arizona. Electronic address: hhan@tgen.org. ·Gastroenterology · Pubmed #30472231.

ABSTRACT: -- No abstract --

91 Editorial A valuable guideline of radioactive 2018

Hertzanu, Yancu / Ye, Xin. ·Department of Radiology, Ben Gurion University, Israel. · Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Ji'nan, China. ·J Cancer Res Ther · Pubmed #30589022.

ABSTRACT:

92 Editorial A Glimmer of Hope for Pancreatic Cancer. 2018

Kindler, Hedy L. ·From the Section of Hematology-Oncology, University of Chicago Medicine, Chicago. ·N Engl J Med · Pubmed #30575492.

ABSTRACT: -- No abstract --

93 Editorial Pancreatic cancer: challenges and opportunities. 2018

Zhu, Huiyun / Li, Tuo / Du, Yiqi / Li, Min. ·Department of Gastroenterology, Changhai Hospital, Shanghai, 200433, China. · Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. · Department of Endocrinology, Changzheng Hospital, Shanghai, 200003, China. · Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. Min-Li@ouhsc.edu. ·BMC Med · Pubmed #30463539.

ABSTRACT: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States, with increasing incidence. The mortality rate of pancreatic cancer is rising rapidly, and is projected to be the second most common of all malignant tumors by 2030. However, the diagnosis and therapy of pancreatic cancer remain a formidable challenge. Recently, enormous efforts have been made to develop several new methods for the early diagnosis and treatment of pancreatic cancer. We briefly introduce the most groundbreaking advances in pancreatic cancer diagnosis and clinical treatment strategies over the past 15 years, including surgery, chemotherapy, endoscopic therapy, immunotherapy and personalized medicine. The signaling pathways that are altered in the progression of pancreatic cancer, which may be used as therapeutic targets, are also discussed.

94 Editorial Impact of preoperative EUS-guided FNA for pancreatic cancer on overall and cancer-free survival: Is the jury still out? 2018

El Hajj, Ihab I / Al-Haddad, Mohammad. ·Division of Gastroenterology and Hepatology, Section of Interventional Endoscopy, Indiana University School of Medicine, Indianapolis, Indiana, USA. ·Gastrointest Endosc · Pubmed #30449404.

ABSTRACT: -- No abstract --

95 Editorial Refining Classification of Pancreatic Cancer Subtypes to Improve Clinical Care. 2018

Aguirre, Andrew J. ·Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts and Broad Institute of MIT and Harvard, Cambridge, Massachusetts. Electronic address: Andrew_Aguirre@dfci.harvard.edu. ·Gastroenterology · Pubmed #30419209.

ABSTRACT: -- No abstract --

96 Editorial Novel and emerging innate immune therapeutic targets for pancreatic cancer. 2018

Wang, Liang / Shureiqi, Imad / Stroehlein, John R / Wei, Daoyan. ·a Department of Gastroenterology, Hepatology and Nutrition , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. · b Department of Gastrointestinal Medical Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. · c Department of Patient Affairs , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. ·Expert Opin Ther Targets · Pubmed #30332892.

ABSTRACT: -- No abstract --

97 Editorial The Agenda for Accelerating Pancreatic Research. 2018

Andersen, Dana K / Forsmark, Christopher E / Pandol, Stephen J. ·Division of Gastroenterology, Department of Medicine, University of Florida Health Sciences Center, Gainesville, FL. · Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA. ·Pancreas · Pubmed #30325854.

ABSTRACT: -- No abstract --

98 Editorial Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer. 2018

Goggins, Michael G / Lippman, Scott M / Constantinou, Pamela E / Jacks, Tyler / Petersen, Gloria M / Syngal, Sapna / Maitra, Anirban. ·Division of Hematology/Oncology, Department of Medicine, Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA. · Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN. ·Pancreas · Pubmed #30325853.

ABSTRACT: -- No abstract --

99 Editorial Focus on pancreatic cancer. 2018

Silvestris, Nicola / Falconi, Massimo. ·Medical Oncology Unit and Scientific Directorate, Cancer Institute "Giovanni Paolo II", Bari, Italy. Electronic address: n.silvestris@oncologico.bari.it. · Pancreatic Surgery Unit, Pancreas Translational and Research Institute, Scientific Institute, San Raffaele Hospital, University Vita e Salute, Milan, Italy. ·Dig Liver Dis · Pubmed #30301604.

ABSTRACT: -- No abstract --

100 Editorial Features of Immune Cells and the Tumor-Associated Stroma Tango as Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma. 2018

Sonohara, Fuminori / Goel, Ajay. ·Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas. · Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas. Electronic address: Ajay.Goel@BSWHealth.org. ·Gastroenterology · Pubmed #30300611.

ABSTRACT: -- No abstract --

Back · Next